- Home
- TRVI vs BLX Comparison
TRVI vs BLX Comparison
Compare TRVI & BLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRVI | BLX |
|---|---|---|
| Founded | 2011 | 1977 |
| Country | United States | Panama |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.8B |
| IPO Year | 2019 | 1997 |
Fundamental Metrics
Financial Performance| Metric | TRVI | BLX |
|---|---|---|
| Price | $11.16 | $48.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $20.38 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 108.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.71% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.11 |
| Revenue Next Year | N/A | $10.13 |
| P/E Ratio | ★ N/A | $8.26 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.85 | $31.14 |
| 52 Week High | $14.39 | $51.99 |
Technical Indicators
Market Signals| Indicator | TRVI | BLX |
|---|---|---|
| Relative Strength Index (RSI) | 45.26 | 49.97 |
| Support Level | $10.04 | $48.33 |
| Resistance Level | $11.78 | $51.60 |
| Average True Range (ATR) | 0.74 | 1.13 |
| MACD | -0.13 | -0.26 |
| Stochastic Oscillator | 12.35 | 46.55 |
Price Performance
Historical ComparisonAbout TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About BLX Banco Latinoamericano de Comercio Exterior S.A.
Banco Latinoamericano de Comercio Exterior SA provides financial solutions to financial institutions, companies, and investors doing business in Latin America, supporting trade and regional integration. The Bank provides foreign trade solutions to a select client base of American financial institutions and corporations and has developed a network of correspondent banking institutions with access to the international capital markets. It has two business segments: the Commercial Business Segment and the Treasury Business Segment. The majority of its revenue is generated from the Commercial Business segment.